申请人:Chytil Milan
公开号:US20110065694A1
公开(公告)日:2011-03-17
Provided herein are fused imidazolyl compounds, methods of synthesis, and methods of use thereof. The compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, including, e.g., neurological disorders and metabolic disorders. Compounds provided herein inhibit the activity of histamine H3 receptors and modulate the release of various neurotransmitters, such as, e.g., histamine, acetylcholine, norepinephrine, and dopamine (e.g. at the synapse). Pharmaceutical compositions containing the compounds and their methods of use are also provided herein.
本文提供了融合咪唑基化合物,其合成方法以及使用方法。本文提供的化合物可用于治疗、预防和/或管理各种疾病,包括但不限于神经系统疾病和代谢性疾病。本文提供的化合物抑制组胺H3受体的活性,并调节各种神经递质的释放,例如组胺、乙酰胆碱、去甲肾上腺素和多巴胺(例如在突触处)。本文还提供了含有这些化合物的药物组合物及其使用方法。